Marissa V.

Marissa V. has extensive experience in clinical development operations and clinical trial management. Marissa has held various leadership positions in pharmaceutical and biotechnology companies, including Stoke Therapeutics, where they are currently the SVP of Clinical Development Operations. Prior to that, they worked at Wave Life Sciences, Gemini Therapeutics, Curis, Sarepta Therapeutics, ImmunoGen, Sanofi Genzyme, Biogen Idec, and Novartis. Throughout their career, Marissa V. has been responsible for overseeing clinical trial execution, budget management, and delivery of multiple programs in various therapeutic areas, including Multiple Sclerosis, Oncology, Neurology, and Rare Genetic Diseases. Marissa has also exhibited expertise in ensuring compliance with regulatory guidelines, Good Clinical Practices (GCP), and International Conference of Harmonization (ICH) Guidelines. Marissa V.'s work experience demonstrates their leadership in driving successful clinical operations and contributing to the advancement of clinical development strategies.

Marissa V. obtained a Bachelor of Science degree in Biology/Biological Sciences, General from Framingham State College, where they studied from 1992 to 1996. Later on, from 2013 to 2015, they attended London Business School and completed their Sanofi Business Master degree, although the field of study is not specified.